April 23, 2024 Source: drugdu 86
On April 18, 2024, Mr. Yang Jun, General Manager of ANKE Bio's Reproductive and Antiviral Division, together with the division's management team, went to Chengdu Jingze Bio-Pharmaceutical Company Limited to deepen the exchange and cooperation. Mr. Peng Hongwei, Chairman of Jingze Biologicals, Mr. Peng Hui, Director of Jingze Biologicals, and other relevant department heads warmly received them and accompanied them to the seminar.
In the project cooperation docking forum held later, both sides discussed and exchanged around the current industry dynamics of Jingze Bio's core product JZB30, the market competition environment, the progress of the product listing, the open mode of cooperation and other aspects, and reached a unanimous consensus. This marks that the cooperation and promotion of the product has made substantial progress, and the pragmatic cooperation between the two sides has entered into a more comprehensive and deeper new stage, while the common development of the two sides, the basis of mutual benefit and win-win situation will be more solid.
In addition, Mr. Peng Hongwei, the chairman of Jingze Biologicals, mentioned in the discussion that Jingze focuses on the golden track of assisted reproduction with the orientation of clinical demand, and the products in research and development involve the whole line of reproduction products except JZB30, which can realize the full coverage of clinical diagnosis and treatment. In the future, both parties can carry out extensive cooperation in multiple products. With the R&D strength of Jingze and the marketing ability of Anke team, we are confident to jointly promote the establishment of a full set of domestic sex hormone product system.
The communication ended in a pleasant atmosphere. It is believed that with this exchange as an opportunity, both parties will pay more attention to information exchange in the future, promote the development of each other's cooperation details and landing, in order to quickly promote the product listing and occupy the market to play their own energy. Jointly promote the high-quality development of the biomedical industry!
https://mp.weixin.qq.com/s?__biz=MzI1MTIzNDY0Nw==&mid=2247498948&idx=2&sn=9ea9dc484f9537aa70251aa4d58427f3&chksm=e9f4acfcde8325ea9e9c015a5d480f9cca95f4cbe3421c346dd1d3a3479966f07b9669120c00&mpshare=1&scene=1&srcid=0422gVUMUDkOTe33Orxz9uJM&sharer_shareinfo=bfd4714e0d35e8ceeb5b7061ca9c9407&sharer_shareinfo_first=bfd4714e0d35e8ceeb5b7061ca9c9407#rd
By editoryour submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.